Products for Research Use Only
RegisterLogin

BMD4503-1

CAT: 0804-HY-169508Size: 1 EachDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-169508Size:1 Each
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
BMD4503-1 is a quinoxaline derivative. BMD4503-1 can inhibit the LRP5/6-Sclerostin interaction and regulate the Wnt signaling pathway[1].
CAS Number
301357-76-6
UNSPSC
12352005
Target
Wnt
Related Pathways
Stem Cell/Wnt
Field of Research
Others
Smiles
O=C(C)NC1=CC=C(S(=O)(NC2=NC3=C(N=C2NC4=CC=CC=C4)C=CC=C3)=O)C=C1
Molecular Formula
C22H19N5O3S
Molecular Weight
433.48
References & Citations
[1]Choi J, et al. In silico discovery of quinoxaline derivatives as novel LRP5/6-sclerostin interaction inhibitors. Bioorg Med Chem Lett. 2018 Apr 1;28 (6) :1116-1121.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported

Related Products

CatalogName
HY-125146-01BMD4503-2
HY-N6838-011,1,1,1-Kestohexaose
HY-157129AMPK-α1β1γ1 activator 1
HY-1336231,1,1-Tribromoacetone
HY-149536TWIK-1/TREK-1-IN-1
HY-W160628S1,1,1-Trimethoxypropane-d5
HY-133630-011-Bromo-1,1-dichloroacetone
HY-1336291,1,1,3-Tetrachloroacetone
HY-W881439-011- (1,1-Dimethylethyl) tridecanedioate
HY-W032015S11-Bromooctane-1,1-d2

Alternative Products

CatalogName
T204975-01BMD4503-1
T69486-01BMD4503-2
OF59775-011,1,1,1,1-Kestoheptaose
N2864-5.11,1,1,1-Kestohexaose
1120401,1,1,1-Kestohexose
410417-011,1,1-Trichloromethanesulfonic Acid 1,1'-Anhydride
IFA69273-011-Iodobicyclo[1.1.1]pentane

Popular Products